You are browsing the global website, which contains information intended for residents outside of the United States of America (U.S.). This website is not country-specific and therefore may contain information that is not applicable to your country.
Rare Cells, with Single Cell Precision
We offer a menu of FDA-cleared and laboratory-developed tests (LDTs) used to detect and analyze circulating tumor cells in human blood with CELLSEARCH®. This minimally invasive liquid biopsy approach allows these tests to enable optimized patient care and comfort throughout the patient’s therapeutic journey.
Learn more about our Oncology portfolio
Learn more about our commitment in cell-based noninvasive prenatal testing (CB-NIPT)
Find out more about billing options
Learn more about setting up your account and ordering a test
If you already have an existing portal account, you can login here
Discover how our clinical lab service can support biopharma partners and clinical trials
Discover how our custom research lab service can support research projects
Single Cell Analysis
FFPE Analysis
View our complete list of Laboratory Developed Tests
Read the latest news from the Menarini Group
2015 - 10 - 15
Forensic & National Security Sciences Institute to Apply DEPArray™ Technology for Complex Biological Evidence Analysis
SAN DIEGO, Calif. - Oct. 14, 2015 -- Silicon Biosystems, Inc. today announced an alliance with Syracuse University'sForensic & National Security Sciences Institute (FNSSI), one of the nation's leading training and research schools that teach professionals how to use specialized instruments and lab tests to analyze evidence from criminal investigations. Under the agreement, the company will provide FNSSI with a DEPArray™ cell identification and isolation system to process complex biological samples for subsequent human DNA analysis.
The partnership marks the company's entrance into the U.S. forensic human ID market, and follows a similar partnership with a forensic case-processing laboratory serving law enforcement organizations in Italy .
The announcement was made at the International Symposium on Human Identification, held October 12-15 in Grapevine, Texas , where company staff scientist Francesa Fontana , Ph.D., presented, "Digital Resolution of Forensic Biological Mixtures Provides Separation of 100% Pure Cells for Each Contributor for Clear-Cut Genetic Analysis."
Human DNA identification can be impeded by the complexity of a biological sample derived from multiple individuals in a crime scene. Dr. Fontana explained how the DEPArray system can reconcile genetic data from different human contributors in a mixed biological sample. With its ability to identify, isolate and recover blood, sperm, and epithelial cells from complex cellular mixtures, the system enables forensic scientists to examine individual cells, and apply other methodologies to characterize DNA from multiple individual contributors.
About Silicon Biosystems Silicon Biosystems Inc., with its U.S. base in San Diego, Calif. , and its European base in Bologna, Italy , is a wholly owned subsidiary of the Menarini Group ( Florence, Italy ). Silicon Biosystems advances healthcare and personalized medicine by creating technologies and products that help uncover the biological complexities of disease at the level of each single cell. Offering the unique ability to control the movement of individual cells in a disposable cartridge, the DEPArray makes it possible to find, sort, and interrogate individual cells in real time for further analysis or culturing. For more information visit http://www.siliconbiosystems.com.
SOURCE Silicon Biosystems, Inc.
PR Newswire Link HERE
Read More
Login